Insider Trading activities of Bioanalytical Systems Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bioanalytical Systems Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bioanalytical Systems Inc since year 2005. Table 2 shows the detailed insider transactions of Bioanalytical Systems Inc since 2005. The reporting company's ticker symbol is BASI. The reporting company's CIK number is 720154.
The total value of stock buying since 2005 is $296,838.
The total value of stock sales since 2005 is $183,111.
The total value of stock option exercises since 2005 is $267,882.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Bioanalytical Systems Inc (BASI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 5,000 $7,500 0 $0 0 $0
2017-08 10,000 $17,000 0 $0 0 $0
2017-03 0 $0 0 $0 12,500 $13,112
2016-05 2,174 $1,999 0 $0 0 $0
2015-09 3,000 $5,190 0 $0 0 $0
2015-08 6,900 $9,798 0 $0 0 $0
2015-06 0 $0 0 $0 125,500 $174,445
2015-02 10,000 $20,400 0 $0 0 $0
2014-08 0 $0 0 $0 2,500 $2,525
2014-06 0 $0 3,130 $8,263 0 $0
2014-03 0 $0 0 $0 5,000 $5,050
2012-08 101,500 $127,890 0 $0 0 $0
2010-09 10,000 $9,000 0 $0 0 $0
2010-02 1,300 $1,040 0 $0 0 $0
2009-08 1,000 $895 0 $0 0 $0
2008-03 0 $0 2,300 $13,819 0 $0
2008-02 5,000 $29,750 7,900 $47,216 0 $0
2007-12 0 $0 0 $0 3,000 $12,750
2007-11 0 $0 0 $0 7,500 $60,000
2007-09 0 $0 355 $2,332 0 $0
2007-08 0 $0 100 $725 0 $0
2007-02 10,000 $66,376 0 $0 0 $0
2006-06 0 $0 2,900 $16,896 0 $0
2006-05 0 $0 15,000 $93,860 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Bioanalytical Systems Inc insiders (BASI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-08 Neff R Matthew Buy 5,000 1.50 7,500
2017-08-18 Davis Gregory Cole Buy 5,000 1.70 8,500
2017-08-18 Neff R Matthew Buy 5,000 1.70 8,500
2017-03-15 Blumhoff Jill (VP, Finance & CFO) Option Ex 2,500 1.21 3,012
2017-03-01 Downing Philip A (VP, Preclinical Srvcs.) Option Ex 10,000 1.01 10,100
2016-05-27 Dougherty Connie Leigh (VP, Business Development) Buy 423 .92 389
2016-05-23 Dougherty Connie Leigh (VP, Business Development) Buy 96 .92 88
2016-05-19 Dougherty Connie Leigh (VP, Business Development) Buy 1,655 .92 1,522
2015-09-14 Downing Philip A (VP, Preclinical Srvcs.) Buy 3,000 1.73 5,190
2015-08-21 Dougherty Connie Leigh (VP, Business Development) Buy 6,900 1.42 9,798
2015-06-18 Lemke Jacqueline M (President and CEO) Option Ex 125,500 1.39 174,445
2015-02-27 Lemke Jacqueline M (President and CEO) Buy 10,000 2.04 20,400
2014-08-25 Devine John P (VP--Toxicology) Option Ex 2,500 1.01 2,525
2014-06-13 Devine John P (VP--Toxicology) Sale 3,130 2.64 8,263
2014-03-03 Devine John P (VP--Toxicology) Option Ex 5,000 1.01 5,050
2012-08-17 Johnson Richard Allen Buy 10,000 1.26 12,600
2012-08-17 Lemke Jacqueline M (Intrm Pres & CEO, CFO & VP Fin) Buy 20,000 1.26 25,200
2012-08-17 Sullivan A. Charlene Buy 10,000 1.26 12,600
2012-08-17 Landis John B. Buy 30,000 1.26 37,800
2012-08-17 Boulet Larry Steven Buy 11,500 1.26 14,490
2012-08-17 Crabb David W Buy 10,000 1.26 12,600
2012-08-17 Omachinski David L Buy 10,000 1.26 12,600
2010-09-15 Omachinski David L Buy 10,000 .90 9,000
2010-02-22 Crabb David W Buy 1,300 .80 1,040
2009-08-21 Cox Michael R (VP Finance & Administration) Buy 1,000 .90 895
2008-03-12 Kissinger Candice B Sale 200 6.00 1,200
2008-03-11 Kissinger Candice B Sale 200 6.09 1,219
2008-03-10 Kissinger Candice B Sale 200 6.00 1,200
2008-03-06 Kissinger Candice B Sale 100 6.00 600
2008-03-05 Kissinger Candice B Sale 500 6.00 3,000
2008-03-04 Kissinger Candice B Sale 600 6.00 3,600
2008-03-03 Kissinger Candice B Sale 500 6.00 3,000
2008-02-29 Kissinger Candice B Sale 600 6.10 3,657
2008-02-28 Kissinger Candice B Sale 300 6.00 1,800
2008-02-27 Shepperd Richard M (President & CEO) Buy 5,000 5.95 29,750
2008-02-26 Bruntlett Craig S (Senior V P, Sales Development) Sale 2,000 5.99 11,984
2008-02-22 Bruntlett Craig S (Senior V P, Sales Development) Sale 5,000 5.96 29,775
2007-12-13 Shoup Ronald E (Chief Scientific Officer) Option Ex 3,000 4.25 12,750
2007-11-23 Shoup Ronald E (Chief Scientific Officer) Option Ex 4,000 8.00 32,000
2007-11-19 Cordova Emilio (V.P. of Business Development) Option Ex 500 8.00 4,000
2007-11-19 Bruntlett Craig S (Senior V P, Sales Development) Option Ex 2,000 8.00 16,000
2007-11-19 Reeves-kerner Lina L (V.P. Human Resources) Option Ex 1,000 8.00 8,000
2007-09-11 Bruntlett Craig S (Senior V P, Sales Development) Sale 355 6.57 2,332
2007-08-27 Bruntlett Craig S (Senior VP, Sales Development) Sale 100 7.25 725
2007-02-15 Shepperd Richard M (President & Chief Exec. Off.) Buy 2,521 6.88 17,344
2007-02-14 Shepperd Richard M (President & Chief Exec. Off.) Buy 7,479 6.56 49,032
2006-06-28 Baitinger William E (Director) Sale 800 4.54 3,631
2006-06-08 Baitinger William E (Director) Sale 400 6.25 2,500
2006-06-05 Baitinger William E (Director) Sale 300 6.25 1,875
2006-06-01 Shoup Ronald E (Chief Operating Officer) Sale 1,400 6.35 8,890
2006-05-31 Shoup Ronald E (Chief Operating Officer) Sale 5,000 6.25 31,250
2006-05-31 Bruntlett Craig S (Senior V P International Sales) Sale 5,000 6.25 31,250
2006-05-15 Bruntlett Craig S (Sr. Vice Pres. International) Sale 5,000 6.27 31,360

Insider trading activities including stock purchases, stock sales, and option exercises of BASI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bioanalytical Systems Inc (symbol BASI, CIK number 720154) see the Securities and Exchange Commission (SEC) website.